NCT06565143 Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease
| NCT ID | NCT06565143 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Anhui Medical University |
| Condition | Transcranial Alternating Current Stimulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-03-01 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the clinical effect neural mechanism of transcranial alternating current stimulation in early Alzheimer's disease
Eligibility Criteria
Inclusion Criteria: 1. Subject diagnosed with early Alzheimer's disease or related diseases according to NIA-AA criteria. 2. Subjects must have a MMSE score between 10 and 27,indicating mild cognitive impairment or dementia. 3. CDR score ≤ 2. 4. Subject under treatment by IAChE for at least 3 months. 5. psychotropic treatments are tolerated if they were administered and unchanged for at least 3 months. Exclusion Criteria: 1. CDR \> 2 2. Any history or clinical signs of other severe psychiatric illnesses (like major depression,psychosis or obsessive compulsive disorder). 3. History of head injury,stroke,or other neurologic disease. 4. Organic brain defects on T1 or T2 images. 5. History of seizures or unexplained loss of consciousness. 6. Implanted pacemaker,medication pump,vagal stimulator,deep brain stimulator. 7. Family history of medication refractory epilepsy. 8. History of substance abuse within the last 6 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06565143 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Transcranial Alternating Current Stimulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06565143 currently recruiting?
Yes, NCT06565143 is actively recruiting participants. Contact the research team at wangkai1964@126.com for enrollment information.
Where is the NCT06565143 trial being conducted?
This trial is being conducted at Hefei, China.
Who is sponsoring the NCT06565143 clinical trial?
NCT06565143 is sponsored by Anhui Medical University. The trial plans to enroll 40 participants.